Development of Vincristine‐Loaded Nano Graphene Oxides for Dual Therapies Against Canine Anaplastic Carcinoma Cells Obtained From a Dog with Spontaneous Mammary Tumor

Yunus Emre Atay,Sadi Yusufbeyoğlu,Zuhal Hamurcu,Ahsen Güler,Latife Çakir Bayram,Görkem Ekebaş,Cagla Celik,Cemile Yilmaz,Ismail Ocsoy,Yaşar Akar

DOI: https://doi.org/10.1002/slct.202404728

2024-11-30

ChemistrySelect

Abstract:Vincristine loaded graphene oxide (Vin@nGO) was developed for efficiently destroy the primary mammary tumors cell cultured from tumor masses of dogs with spontaneous mammary tumors via simultaneous photothermal therapy (PTT) and chemotherapy under near infrared laser irradiation (NIR, 808 nm). Among pet species, mammary tumors are most commonly encountered in dogs. In the traditional treatment of mammary tumors in dogs; surgical operation, chemotherapy, immunotherapy, cryotherapy, radiotherapy and homeopathy are used. Herein, we reported vincristine loaded nano graphene oxide (Vin@nGO) for simultaneous photothermal therapy (PTT) and chemotherapy under near infrared laser (NIR, 808 nm), whereas GO was used both as a platform for vincristine and as a photothermal (PT) agent, and vincristine was used as a chemotherapeutic agent. Spontaneous mammary tumor masses of a dog were removed and primary tumor cells were obtained and propagated by tissue culture from tumor tissue samples under appropriate conditions. Then, these cells were incubated with Vin@nGO and exposed to NIR laser. NIR laser irradiation at 808 nm was converted to heat by nGO, then the target cancer cells were destroyed by both hyperthermia and chemotherapy. MTS analysis was performed to test the effectiveness of this dual therapy on cell proliferation and a statistically significant (p

chemistry, multidisciplinary